Patrick Hwu
Impact in
- Immunology top 0.05%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.1%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 148
- Cancer Immunotherapy and Biomarkers 80
- CAR-T cell therapy research 76
- Immunology 133
- Immunotherapy and Immune Responses 111
- Immune Cell Function and Interaction 41
- T-cell and B-cell Immunology 30
- Co-authors
- Nicholas P. Restifo (14 shared papers)Steven A. Rosenberg (18 shared papers)Willem W. Overwijk (30 shared papers)Réjean Lapointe (11 shared papers)Laszlo Radvanyi (31 shared papers)Gregory Lizée (28 shared papers)Yanyan Lou (12 shared papers)Suzanne L. Topalian (6 shared papers)
- Journals
- Journal of Clinical Oncology (37 papers)Clinical Cancer Research (15 papers)The Journal of Immunology (13 papers)Journal of Immunotherapy (11 papers)Journal for ImmunoTherapy of Cancer (11 papers)
- Partner nations
- United StatesAustraliaChina
In The Last Decade
Patrick Hwu
216 papers receiving 15.6k citations
Patrick Hwu's Hit Papers
Peers
Comparison fields: 5 of 132
- Immunology 10.0k
- Oncology 9.4k
- Biological Psychiatry 470
- Cancer Research 1.0k
- Molecular Biology 4.4k
Countries citing papers authored by Patrick Hwu
This map shows the geographic impact of Patrick Hwu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Hwu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Hwu more than expected).
Fields of papers citing papers by Patrick Hwu
This network shows the impact of papers produced by Patrick Hwu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Hwu. The network helps show where Patrick Hwu may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Hwu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 220 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes Hit paper breakdown → | 2002 | 2170 |
| 2 | PD-L1 Expression in Triple-Negative Breast Cancer Hit paper breakdown → | 2014 | 1065 |
| 3 | Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy Hit paper breakdown → | 2016 | 913 |
| 4 | T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity Hit paper breakdown → | 2009 | 618 |
| 5 | Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation Hit paper breakdown → | 2000 | 617 |
| 6 | STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity Hit paper breakdown → | 2015 | 447 |
| 7 | 2010 | 387 | |
| 8 | Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma Hit paper breakdown → | 2016 | 349 |
| 9 | 2012 | 340 | |
| 10 | 1999 | 335 | |
| 11 | 2015 | 282 | |
| 12 | 2001 | 279 | |
| 13 | 1997 | 267 | |
| 14 | 2008 | 256 | |
| 15 | 2001 | 242 | |
| 16 | In vivo antitumor activity of T cells redirected with chimeric antibody/T-cell receptor genes. | 1995 | 226 |
| 17 | In vivo antitumor activity of interleukin 21 mediated by natural killer cells. | 2003 | 190 |
| 18 | Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. | 1996 | 189 |
| 19 | 2020 | 185 | |
| 20 | 2010 | 173 |
About Patrick Hwu
Patrick Hwu is a scholar working on Oncology, Immunology, Molecular Biology, Genetics and Pulmonary and Respiratory Medicine, having authored 220 papers that have together received 15.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (111 papers), Cancer Immunotherapy and Biomarkers (80 papers), CAR-T cell therapy research (76 papers), Immune Cell Function and Interaction (41 papers), T-cell and B-cell Immunology (30 papers), Virus-based gene therapy research (24 papers), vaccines and immunoinformatics approaches (19 papers) and Melanoma and MAPK Pathways (15 papers). The work is most often cited by research in Immunology (10.0k citations), Oncology (9.4k citations), Biological Psychiatry (470 citations), Cancer Research (1.0k citations) and Molecular Biology (4.4k citations). Patrick Hwu has collaborated with scholars based in United States, Australia and China. Frequent co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Willem W. Overwijk, Réjean Lapointe, Laszlo Radvanyi, Gregory Lizée, Yanyan Lou, Suzanne L. Topalian, Douglas J. Schwartzentruber and John R. Wunderlich. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, The Journal of Immunology, Journal of Immunotherapy and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.